If SAMHSA Seriously Wants to Destigmatize People with Substance Use Disorder, It Can Start by Destigmatizing How They Receive Treatment
Jeffrey A. Singer
In 2001, the Food and Drug Administration transferred regulation of methadone treatment programs for opioid use disorder (nowadays called Opioid Treatment Programs or OTPs) to the Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration. DEA and SAMHSA work together to establish and enforce criteria for treating people with substance use disorder and the regulations that govern how health care practitioners prescribe and administer... Читать дальше...